Sarwer, PhD, director of the Center for Obesity Research and Education, Temple University, and a spokesperson for the Obesity Society who wasnt involved in the research
However, evidence on longer-term effects and side effects remains limited or uncertain, partly due to potential conflicts of interest
What is the recommended starting dose of semaglutide (glucagonlike peptide1 receptor agonist) for initiating therapy in a patient with type 2 diabetes?
This could be particularly beneficial for people with complex conditions such as T2D, obesity, and cardiovascular disease
Also in China, Eli Lilly recently filed for approval of a new GLP-1 treatment and completed a Phase 1 trial for a related medication
In addition, yet another study focused on the conjunction of glutathione and L-citrulline supplementation highlights the fruitful alliance between the two when it comes to physical performance and muscle growth